You are here: Home » Companies » News
Business Standard

Aurobindo Pharma gets USFDA nod to market potassium chloride pills in US

The potassium chloride tablets are for treating hypokalemia, a condition wherein there is a drop in the potassium-level in the blood

Press Trust of India  |  Hyderabad 

Aurobindo Pharma
Representative Image

Ltd Friday said it has got the approval of the (USFDA) to make and market chloride tablets of 600 mg and 750 mg for the US market.

The tablet, a generic version of Upsher-Smith's Klor-Con extended release tablets, would be launched next month, said a press release here.

The chloride tablets are for treating hypokalemia, a condition wherein there is a drop in the potassium-level in the blood.

The drug has an estimated market size of USD 60 million for 12 months ending October 2018, the release said quoting market reports.

First Published: Fri, December 21 2018. 15:45 IST
RECOMMENDED FOR YOU